Literature DB >> 305728

The dose-response relationships of dipivalyl epinephrine in open-angle glaucoma.

G K Krieglstein, W Leydhecker.   

Abstract

The intraocular pressure responses of topically applied dipivalyl epinephrine (DPE: 0.025, 0.1, and 0.25%) were investigated in three series of open angle glaucoma patients in a double blind study. IOP responses were compared intra-individually with the effects of 1% epinephrine hydrochloride. 0.1% DPE gave an IOP reduction similar to that of 1% epinephrine-HCl. The change in IOP was less with 0.025% DPE and statistically significantly greater with 0.25% DPE when compared with the conventional epinephrine preparation. The clinical advantages of the 'pro drug' DPE are pointed out.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 305728     DOI: 10.1007/bf00414393

Source DB:  PubMed          Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol        ISSN: 0065-6100


  4 in total

1.  Madarosis in chronic epinephrine therapy.

Authors:  M A Kass; R L Stamper; B Becker
Journal:  Arch Ophthalmol       Date:  1972-10

Review 2.  Permeability of the cornea to topically applied drugs.

Authors:  H Benson
Journal:  Arch Ophthalmol       Date:  1974-04

3.  Topical epinephrine and cystoid macular edema.

Authors:  S A Obstbaum; M A Galin; T A Poole
Journal:  Ann Ophthalmol       Date:  1976-04

4.  The effects of dipivalyl epinephrine on the eye.

Authors:  M B Kaback; S M Podos; T S Harbin; A Mandell; B Becker
Journal:  Am J Ophthalmol       Date:  1976-06       Impact factor: 5.258

  4 in total
  7 in total

Review 1.  Prodrugs.

Authors:  D G Waller; C F George
Journal:  Br J Clin Pharmacol       Date:  1989-11       Impact factor: 4.335

2.  Soluble forms of isobutylmethylxanthine enhance the ocular hypotension induced by catecholamines.

Authors:  M J Busch; P F Hoyng
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

Review 3.  Pharmacological therapy for glaucoma: a review.

Authors:  P F Hoyng; L M van Beek
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

Review 4.  Clinical pharmacokinetics of various topical ophthalmic delivery systems.

Authors:  J P Frangie
Journal:  Clin Pharmacokinet       Date:  1995-08       Impact factor: 6.447

5.  [The effect of timolol and dipivalyl-epinephrine in the treatment of the elevated intraocular pressure (author's transl)].

Authors:  M Ober; A Scharrer
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1980

6.  Nerve terminal degeneration in the rat iris observed following chronic topical 2% epinephrine and 0.1% dipivalyl epinephrine: a quantitative comparison of electron microscopic observations and tissue norepinephrine levels.

Authors:  A J Flach; M E Donahue; I S Wood
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

7.  A single-blind randomised trial comparing adrenaline 1.0% with dipivalyl epinephrine (propine) 0.1% in the treatment of open-angle glaucoma and ocular hypertension.

Authors:  K B Mills; N A Jacobs
Journal:  Br J Ophthalmol       Date:  1988-06       Impact factor: 4.638

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.